期刊文献+

湖北地区三级医院2002~2005年克雷伯菌属耐药性变迁分析

Analysis of antibiotic resistant changing in Klebsiella pneumonia in the third grade hospitals of Hubei province.
下载PDF
导出
摘要 目的 调查湖北地区克雷伯菌属的耐药性及流行趋势,为,临床提供诊疗依据。方法 采用WHO NET4-5软件对3992株克雷伯菌属菌株的耐药率进行统计分析。菌株分离自湖北地区17所三级医院2002~2005年成人患者各类临床标本。结果 4年中湖北地区克雷伯菌属对常用抗菌药物的耐药率基本持平或略有上升,对氨苄西林耐药率高达98%~99%;对亚胺培南100%敏感。产超广谱G内酰胺酶(ESBLs)菌株的检出率呈上升趋势,由27.2%上升到35.4%。结论4年来湖北地区克雷伯菌属的耐药率基本持平,说明坚持细菌耐药性监测与公示,合理使用抗生素,对控制耐药菌的传播与流行是有效的。 Objective To explore antibiotic resistance in KlebsieUa pneumonia and the epidemiological character of these strains. Provide available antibiotic selecting methods for the clinical treatment. Methods Provide statistic analysis to the antibiotic resistant ratio in 3992 isolates of Klebsiella pneumonia by WHO NET4 - 5 software. The strains were recovered from all kinds of clinical specimens of adult patients in 17 3rd grade hospitals in Hubei province. Results In the four years,the resistance to antibiotics in Klebsiella pneumonia was on slight rise;the resistance to ampieillin was 98% - 99% ;all of these strains wrer susceptible to imipenem.The ratio of ESBLs in this period increased from 27.2% to 35.4% .Conclusion Antibiotic resistance of Klebsiella pneumonia in Hubei province was not on rise. It is efficient to control the occurrence and spread of the drug resistant bacteria by monitoring antibiotic resistance and using antibiotics appropriately.
出处 《四川医学》 CAS 2006年第11期1111-1112,共2页 Sichuan Medical Journal
基金 湖北省自然科学基金资助项目(2004ABA153)
关键词 湖北地区 三级医院 克雷伯菌属 耐药性 hubei province third grade hospital klebsiella pneumonia antibiotics resistance
  • 相关文献

参考文献2

二级参考文献18

  • 1张亚莉,史占军,李中齐,耿穗娜,李琼,汪能平.大肠埃希菌、肺炎克雷伯菌产超广谱β-内酰胺酶菌株的耐药性监测[J].中华医院感染学杂志,2004,14(3):331-333. 被引量:83
  • 2汪复.抗菌药物合理应用的几个问题[J].中国抗感染化疗杂志,2005,5(1):1-3. 被引量:99
  • 3叶惠芬,陈惠玲,杨银梅,李红玉,苏丹虹,黄露霞.2003年广州地区常见病原菌耐药性调查[J].中国抗感染化疗杂志,2005,5(1):29-32. 被引量:39
  • 4Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 5Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 6Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 7Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 8National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 9Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 10汪复.产β-内酰胺酶耐药菌感染的防治策略[J].中华传染病杂志,2000,18(3):149-150. 被引量:45

共引文献515

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部